Symbol
| METTL3
| contributors: mct - updated : 05-11-2019
|
HGNC name
| methyltransferase like 3
|
HGNC id
| 17563
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
|  
| loss of function
|
significantly augments calcium deposition and enhances alkaline phosphatase activity of mesenchymal stem cells, uncovering an inhibitory role of METTL3 in osteogenesis | tumoral
|  
|  
|  
| gain of function
|
in gastric cancer | constitutional
|  
| deletion
|  
|  
|
of METTL3 from the adult haematopoietic system led to an accumulation of Haematopoietic stem cells (HSCs) in the bone marrow and a marked reduction of reconstitution potential due to a blockage of HSC differentiation | constitutional
|  
|  
|  
|  
|
silencing METTL3 could sustain long-chain fatty acids (LCFAs) absorption through blocking the TRAF6-dependent inflammation response | tumoral
|  
|  
| --over
|  
|
in lung adenocarcinoma | tumoral
|  
|  
| --low
|  
|
of METTL3 and METTL14 expressions in childhood ETV6/RUNX1-positive acute lymphoblastic leukemia | tumoral
|  
|  
| --over
|  
|
in cervical tumor tissues | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| elevated METTL3 level was predictive of poor prognosis in gastric cancer | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | head and neck | | |
METTL3 might be a potential target for cervical cancer therapy |
| | |
| Mettl3 overexpression in MSCs protects the mice from estrogen deficiency-induced osteoporosis |